Follow
Nitesh K Kunda
Nitesh K Kunda
Assistant Professor, St. John's University
Verified email at stjohns.edu
Title
Cited by
Cited by
Year
Nanocarriers targeting dendritic cells for pulmonary vaccine delivery
NK Kunda, S Somavarapu, SB Gordon, GA Hutcheon, IY Saleem
Pharmaceutical research 30, 325-341, 2013
1142013
Exosomes as drug delivery systems: a brief overview and progress update
SM Patil, SS Sawant, NK Kunda
European Journal of Pharmaceutics and Biopharmaceutics 154, 259-269, 2020
1132020
Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles
NK Kunda, IM Alfagih, EN Miyaji, DB Figueiredo, VM Gonçalves, ...
International journal of pharmaceutics 495 (2), 903-912, 2015
702015
Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer
X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ...
International Journal of Biological Macromolecules 164, 638-650, 2020
692020
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
R Vartak, SM Patil, A Saraswat, M Patki, NK Kunda, K Patel
Nanomedicine 16 (14), 1187-1202, 2021
662021
An overview of nanocarrier-based adjuvants for vaccine delivery
KC Petkar, SM Patil, SS Chavhan, K Kaneko, KK Sawant, NK Kunda, ...
Pharmaceutics 13 (4), 455, 2021
652021
Bovine Serum Albumin Adsorbed PGA-co-PDL Nanocarriers for Vaccine Delivery via Dry Powder Inhalation
NK Kunda, IM Alfagih, SR Dennison, HM Tawfeek, S Somavarapu, ...
Pharmaceutical research 32, 1341-1353, 2015
652015
Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment
V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ...
Pharmaceutics 12 (3), 206, 2020
612020
Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics
B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ...
International journal of pharmaceutics 577, 118995, 2020
592020
Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD)
A Mohamed, NK Kunda, K Ross, GA Hutcheon, IY Saleem
European Journal of Pharmaceutics and Biopharmaceutics 136, 1-8, 2019
592019
Development of novel octanoyl chitosan nanoparticles for improved rifampicin pulmonary delivery: optimization by factorial design
KC Petkar, S Chavhan, N Kunda, I Saleem, S Somavarapu, KMG Taylor, ...
AAPS PharmSciTech 19, 1758-1772, 2018
582018
In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles
DN Price, LR Stromberg, NK Kunda, P Muttil
Molecular pharmaceutics 14 (12), 4741-4750, 2017
582017
Antimicrobial peptides as novel therapeutics for non-small cell lung cancer
NK Kunda
Drug discovery today 25 (1), 238-247, 2020
572020
Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
TC Rodrigues, MLS Oliveira, A Soares-Schanoski, SL Chavez-Rico, ...
PloS one 13 (1), e0191692, 2018
562018
Polymer‐based Delivery Systems for the Pulmonary Delivery of Biopharmaceuticals
NK Kunda, IM Alfagih, IY Saleem, GA Hutcheon
Pulmonary Drug Delivery: Advances and Challenges, 301-320, 2015
55*2015
Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer
L Zhai, R Yadav, NK Kunda, D Anderson, E Bruckner, EK Miller, R Basu, ...
Antiviral research 166, 56-65, 2019
532019
Microbes as medicines: harnessing the power of bacteria in advancing cancer treatment
SS Sawant, SM Patil, V Gupta, NK Kunda
International journal of molecular sciences 21 (20), 7575, 2020
512020
Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer
SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ...
Pharmaceutical research 37, 1-19, 2020
492020
Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ...
Drug delivery and translational research 11, 927-943, 2021
452021
Inhalable bedaquiline-loaded cubosomes for the treatment of non-small cell lung cancer (NSCLC)
SM Patil, SS Sawant, NK Kunda
International Journal of Pharmaceutics 607, 121046, 2021
432021
The system can't perform the operation now. Try again later.
Articles 1–20